Many patients receiving compounded semaglutide vials report struggling with self-injections, according to adverse event reports. Patients' lack of experience with withdrawing medication into a ...

Scientists are trying to tackle Alzheimer's from all angles, and a new study adds to the growing evidence that semaglutide, a ...

Novo (NVO) offers injector pen versions of its weight loss therapy semaglutide marketed as Wegovy at $650 for a month’s supply, and the Danish drugmaker doesn’t sell the GLP-1 in vial formats.

The Indiana-based drugmaker is slashing the prices of its 2.5 mg single-dose vials to $349 per month ... Zepbound's biggest rival was Novo Nordisk and its semaglutide-based products Wegovy and ...

The FBI says counterfeit versions of the drugs can cause health issues. The FBI is warning the public about counterfeit compounded weight loss drugs on the market that claim to contain semaglutide ...

Makers of copycat versions of Novo Nordisk's (NVO) popular weight-loss drug semaglutide, also known as Ozempic and Wegovy, are suing the FDA for removing the GLP-1 medication from its shortage list.